ADDRESSING LIVER FAILURE AND
ADVANCED LIVER DISEASE

Ponte Biosciences, Inc. is a preclinical biotherapeutic company focused on developing a cell-based bioartificial liver system targeting the treatment of acute forms of liver failure. The Company’s Spheroid Reservoir Bioartificial Liver (SRBAL) System was developed at the Mayo Clinic and utilizes metabolically active primary hepatocytes to replace or supplement liver function for Intensive Care Unit (ICU) patients in liver failure. Ponte Biosciences, Inc. is based in Rochester, MN.